Search Results 1001-1010 of 18400 for Immunode

1. A Study of Nivolumab and Multi-fraction Stereotactic Radiosurgery with or without Ipilimumab in Treating Participants with Recurrent Grade II-III Meningioma - Mayo Clinic

   However, patients with human immunodeficiency virus (HIV) on stable therapy with minimal viral loads and patients with hepatitis B and hepatitis C who have ...

2. A Study to Evaluate Mutanome-directed Immunotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   Known history of positive testing for Human Immunodeficiency Virus (HIV) or known Acquired Immune Deficiency Syndrome (AIDS). Clinical or laboratory history ...

3. A Study Evaluating AMG 424 in Subjects With Multiple Myeloma - Mayo Clinic

   Known positivity for Human Immunodeficiency Virus (HIV). Baseline ECG QTc > 470 msec. History of malignancy other than multiple myeloma within the past 5 ...

4. A Study to Evaluate Pevonedistat and Venetoclax Plus Azacitidine in Adults with Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy - Mayo Clinic

   Patient has uncontrolled human immunodeficiency virus (HIV) infection. Note: Known HIV positive participants who meet the following criteria will be ...

5. Rem-422, an MYB mRNA Degrader, in Patients With Relapsed/Refractory AML or Higher-Risk MDS - Mayo Clinic

   Primary immunodeficiency. Current or expected need for daily systemic corticosteroid therapy ≥ 10 mg of prednisone equivalent. Note: Patients who are ...

6. Study of Oral LOXO-338 in Patients With Advanced Blood Cancers - Mayo Clinic

   - Known human immunodeficiency virus (HIV) positive, regardless of cluster of differentiation 4 (CD4) count. Unknown or negative status eligible ...

7. A Study to Evaluate MUC1 Vaccine to Prevent Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer - Mayo Clinic

   ... immunodeficiency virus (HIV) - Known autoimmune disease - Known non‐alcoholic steatohepatitis (NASH) or non‐alcoholic fatty liver disease (NAFLD) - History ...

8. A Study To Assess Efficacy And Safety Of Pembrolizumab With Or Without Sacituzumab Tirumotecan (MK- 2870) In Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) - Mayo Clinic

   * Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on antiretroviral therapy (ART) * Participants who are hepatitis B ...

9. Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma - Mayo Clinic

   History or evidence of melanoma associated with immunodeficiency states (eg, hereditary immune deficiency, organ transplant, or leukemia); Phase 1b: History ...

10. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

    Known history of testing positive for human immunodeficiency virus (HIV), known acquired immunodeficiency syndrome (AIDS). Active hepatitis B (serum ...